Physician profile
Christopher Adam Merrell
NPI 1720049182
$7,330.17
in general payments reported to CMS, 2019-2025
18 companies · $430 in 2025
The $430 reported for 2025 was more than what 76% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $2,994 · 2021: $552 · 2022: $716 · 2023: $660 · 2024: $1,133 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,917.27 | 2021-2025 | Accurian, Intellis Adaptivestim, Synchromedii |
| Arthrex, INC. | $2,152.12 | 2020 | |
| Medtronic USA, INC. | $737.39 | 2019-2020 | |
| Peerless Surgical INC. | $572.01 | 2019-2020 | |
| Boston Scientific Corporation | $294.45 | 2020-2025 | General - Pain Management, Intracept, Coveredge 32 |
| Abbott Laboratories | $231.65 | 2019-2023 | Axium, Proclaim, Penta |
| Amgen INC. | $112.99 | 2019 | |
| Nevro Corp. | $70.28 | 2019 | |
| Zyla Life Sciences, INC. | $41.30 | 2020 | |
| Forte Bio-Pharma LLC | $32.90 | 2023-2024 | Prolate, Nalocet |
| Relievant Medsystems, INC. | $31.03 | 2023 | Intracept |
| Spr Therapeutics, INC | $28.92 | 2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $27.69 | 2025 | |
| Daiichi Sankyo INC. | $23.15 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.13 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.46 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.72 | 2019 | |
| Assertio Therapeutics, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Merrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.